M. Porterootin et al., CHROMATOGRAPHIC EVIDENCE FOR PYRRALINE FORMATION DURING PROTEIN GLYCATION IN-VITRO AND IN-VIVO, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1247(1), 1995, pp. 74-80
Pyrraline (formyl-5-hydroxymethyl-pyrrol-1-yl)-L-norleucine) is an adv
anced Maillard reaction product formed from 3-deoxyglucosone in the no
n-enzymatic reaction between glucose and the epsilon-amino group of ly
sine residues on proteins. Although its presence in vivo as well as in
in vitro incubations of proteins with sugars has been documented by i
mmunochemical methods using polyclonal and monoclonal antibodies, its
formation in proteins has recently been questioned by similar methodol
ogy. To clarify this issue, we investigated pyrraline formation in pro
teins following alcaline hydrolysis and quantitation by high-performan
ce liquid chromatography on a C-18 reverse-phase column. Time- and sug
ar concentration-dependent increase in pyrraline formation was noted i
n serum albumin incubated with either 100 mM glucose or 50 mM 3-deoxyg
lucosone. Formation of pyrraline from 3-deoxyglucosone was rapid at sl
ightly acidic pH, confirming its synthetic pathway through this Mailla
rd reaction intermediate. Low levels of pyrraline(< 10 pmol/mg protein
) were also detected in a pool of human skin collagen by this method,
but no age effect was apparent. Using a slightly different approach, p
yrraline-like material was detected in human plasma proteins following
enzyme digestion and analysis by high performance liquid chromatograp
hy. Plasma from diabetic patients showed a significant increase in pyr
raline-like material compared to controls. The levels in diabetic and
normal individuals were 21.6 +/- 9.56 and 12.8 +/- 5.6 pmol per mg pro
tein, respectively (P = 0.005), reflecting thereby the elevated levels
of the immediate precursor of pyrraline, 3-deoxyglucosone, in diabeti
c plasma.